Flash Glucose Monitoring has now been approved by NHS Greater Huddersfield Clinical Commissioning Group and NHS North Kirklees Clinical Commissioning Group for patients with type 1 diabetes mellitus in the following circumstances:
- Patients with Type 1 diabetes mellitus and;
- Aged four and above and;
- Under specialist care and;
- Using multiple daily injections of insulin, or insulin pump therapy,
- Whom the specialist considers the use of the device will be cost- effective
Meets one or more of the following criteria:
- Meet current NICE criteria for insulin pump therapy (HbA1c ≥69.4 mmol/mol (8.5%) or disabling hypoglycaemia as described in NICE TA151) where a successful trial of a Flash Glucose Monitoring System (FGS) System may avoid the need for pump therapy
- Recently developed impaired awareness of hypoglycaemia such that there is an inability to detect the onset of hypoglycaemia because of absence of warning symptoms. The individual must also demonstrate a willingness to engage with further education where applicable and a high level of engagement with glucose testing and management. (Note that for persistent hypoglycaemia unawareness, NICE recommends continuous glucose monitoring with alarms and FGS do not currently have this function).
- Two or more admissions to hospital per year with diabetic ketoacidosis or hypoglycaemia
- Patients or carer of a patient who have considerable difficulties in finger prick testing due to physical or mental health limitations
- Patients or carer of a patient with functional impairment that impacts on their ability to interpret standard finger prick testing results
Reluctance to carry out finger prick testing (e.g. due to distress or inconvenience) alone is not considered to be criteria qualifying the use of FGS.